Decera Clinical

What Decera Clinical does

Decera Clinical, operating under Clinical Education Alliance, LLC and formerly known as CCO (Clinical Care Options), is a privately held medical education and healthcare professional engagement company headquartered in Reston, Virginia. Founded in 2006 with operational roots spanning more than 25 years, the company operates three integrated divisions — Decera Clinical Education (accredited CME/CE programs), Decera Clinical Insights (HCP market research and intelligence), and Decera Clinical Communications (scientific communications and field-ready content) — unified by a proprietary Scientific Activation™ methodology structured around the DECODE process (Detect Signal, Connect to Context, Design to Activate).

The underlying technology is a digital medical education and HCP engagement platform delivering accredited continuing education across 20+ specialties, maintaining a validated proprietary network of more than 1.4 million healthcare professionals across 70+ therapeutic areas. The company claims 90% reach in high-value therapeutic areas and an NPS of 70+ among HCPs, with subsidiary platforms including interactive decision support tools, mobile applications with location-based services, and recently launched AI-powered communications solutions. The portfolio is extended through wholly-owned subsidiaries including MDOutlook (HCP intelligence), liV (Canadian medical education), Partners for Advancing Clinical Education, ProCE (pharmacy CE), and Practicing Clinician Exchange.

Decera Clinical generates revenue primarily through enterprise B2B professional services sold to life sciences organizations — pharmaceutical and biotechnology companies that sponsor accredited CME/CE programming, commission HCP insights research, and engage the firm for scientific communications support across the full product lifecycle. Secondary revenue streams include sponsored content and advertising on the HCP-facing network and grant funding for educational programming. The company reports partnerships with 100% of Top 20 global pharmaceutical companies and 70+ biopharma partners worldwide, served through direct enterprise sales, with multi-year contract structures. Geographic coverage spans North America (US and Canada via liV) with global claims for pharma partner engagement.

Name

Decera Clinical

Legal name

Clinical Education Alliance, LLC

Website

https://corporate.deceraclinical.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Decera Clinical is a privately held medical education and HCP engagement company that delivers accredited CME/CE, HCP market insights, and scientific communications to pharmaceutical and biotechnology partners, leveraging a proprietary network of 1.4M+ healthcare professionals across 20+ specialties.

Ownership category

akta.pro rank

Product category

Medical Education and Healthcare Communications

NAICS

Educational Support Services (61171)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Medical education services
• HCP engagement platforms
• Scientific communications
• Healthcare market research
• Accredited CME programs

Headquarters

HQ city

Reston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Accredited CME/CE Education Services: Decera Clinical delivers accredited continuing medical education (CME) and continuing education (CE) programs to healthcare professionals across 20+ specialties. Revenue is generated through partnerships with life sciences companies (pharma, biotech) who sponsor or commission educational programming, as well as grants from medical education companies and accreditation bodies.
2. HCP Insights Research Services: Decera Clinical Insights provides market research and intelligence services to life sciences partners, delivering strategic clarity on prescribing barriers, adoption drivers, and competitive dynamics through surveys, expert panels, and qualitative research with practicing HCPs.
3. Scientific Communications Services: Medical communications services including scientific platforms, content development, field-ready resources, and strategic publications support for pharma and biotech partners across the product lifecycle.
4. Sponsored Content & Advertising: The company accepts advertising on its Decera Clinical Network from third parties including sponsored webinars, expert reports, whitepapers, surveys, and email distributions. Registration and account creation are required to access sponsored content.
5. Grant Funding: Decera Clinical receives grant funding from various sources for educational programming, and provides aggregated, de-identified data about users to grant funders for program evaluation purposes.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Decera Clinical provides accredited continuing medical education (CME/CE), HCP insights and market research, and scientific communications services to pharmaceutical and biotechnology companies. Through its proprietary Activeer™ network of 1.4M+ healthcare professionals and Scientific Activation™ methodology, the company translates complex clinical evidence into education, insights, and communications that drive clinical adoption across 20+ specialties and 70+ therapeutic areas.

Product overview

Decera Clinical is a multi-platform healthcare education and communications company operating under Clinical Education Alliance LLC. The portfolio comprises three core divisions—Decera Clinical Education (formerly CCO) for accredited CME/CE programs, Decera Clinical Insights for HCP intelligence and market research, and Decera Clinical Communications for scientific communications—supported by the proprietary Scientific Activation (DECODE) methodology. The ecosystem also includes liV as a Canadian-focused sub-brand and Partners for Advancing Clinical Education as a partnership entity. The company delivers accredited education, HCP insights, and strategic communications to life sciences organizations, with mobile applications featuring interactive decision support tools and location-based services.

Differentiator

Problem solved

Functional benefit

Products and services

• Decera Clinical Education (formerly CCO) Accredited CME/CE programs grounded in deep clinical expertise, delivering thousands of learning activities and events across more than 40 specialties with direct reach into 1.4M+ healthcare professionals. Targeted at life sciences companies that sponsor or commission educational programming.
• Decera Clinical Insights

Quantifiable outcome

• 1 in 5 patients seen by HCPs trained through Decera Clinical Education are positively impacted
• +4 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• liV (Agence L.I.V. Inc.)coreStrategic or Co-development PartnerliV, powered by Decera Clinical, is Canada's leading medical education and communications agency. Based in Canada with operations at livagency.ca, liV delivers customized, science-grounded programs across therapeutic areas, helping life sciences partners engage HCPs and advance clinical practice in Canada and globally. Fully integrated as a regional subsidiary under the Decera Clinical umbrella.
• Partners for Advancing Clinical EducationcoreStrategic or Co-development PartnerPartners for Advancing Clinical Education (PACE) operates as a subsidiary under Decera Clinical, offering specialized continuing education services. Available at partnersed.com as part of the Decera Clinical Network of educational properties.
• Top 20 Global Pharmaceutical CompaniescoreOthersDecera Clinical maintains partnerships with 100% of Top 20 global pharmaceutical companies for educational programming, insights research, and scientific communications services. These are strategic client relationships where pharma companies sponsor or commission educational content and engage Decera Clinical for HCP intelligence.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: Global life sciences services and technology platform with significant real-world insights, HCP engagement, and medical affairs capabilities. Overlaps with Decera's insights franchise but operates across a far broader portfolio.
• IPG Health: Holding-company network of healthcare and medical communications agencies (including CMC Connect, Caudex, Complete Regulatory). Competes with Decera Clinical Communications for global pharma medcomms mandates.
• OMNICOM Health Group: Healthcare marketing and communications network offering medical education, advertising, and medical communications across multiple specialty agencies. Competes with Decera Clinical across medcomms and CME/CE work.
• Syneos Health: Biopharmaceutical solutions organization spanning clinical development, medcomms, and commercialization with HCP education offerings. Comparable adjacent competitor in medical communications and HCP engagement for pharma clients.

Direct peers

• Medscape (WebMD Health): Flagship HCP platform offering accredited CME/CE, clinical news, and decision-support tools to a large global physician audience. Directly comparable to Decera Clinical Education in CME/CE delivery, HCP reach model, and pharma-sponsorship revenue streams.
• Doximity: Largest U.S. verified-physician professional network with CME, news, and sponsored content products. Comparable to Decera Clinical's HCP network and pharma-sponsored educational content distribution.
• Guidepoint: Expert network and HCP/market-research provider offering pharmaceutical clients qualitative insights from healthcare professionals. Closely comparable to Decera Clinical Insights in expert-panel and market-research service delivery.
• Continuum Clinical: Medical education and patient-focused communications provider serving pharma and biotech with CME/CE and insights services. Directly comparable in scope to Decera Clinical's Education and Insights divisions.
• M3 USA: Operates large HCP panels and market-research networks (MDlinx, The Doctor's Channel) serving pharma with insights and continuing education. Overlaps with Decera Clinical on HCP market-research services and digital HCP engagement.
• Real Chemistry: Independent healthcare communications and data-driven marketing agency serving pharma/biotech across medical communications, PR, and HCP engagement. Comparable to Decera Clinical's Communications and Insights offerings for life sciences clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cealliance

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Decera Clinical